A pH-responsive polyamidoamine dendritic nanocarrier-incorporated hydrogel can serve as a drug delivery system to bind immunochemotherapy drugs, induce immunogenic cell death-related cytokines, and trigger CD8+ T cell-mediated immune responses to enhance immunogenic cell death and reverse immunosuppression, leading to significant tumor growth inhibition (50). The gene discussed is CD8A; the disease is neoplasm.